Skip to content
MenuOpen navigation menu

Real moms, real GLP-1 talk

GLP-1 Injection Sites: Scars, Stretch Marks and Rotation

Wegovy pen instructions say to avoid scars and stretch marks. The approved alternatives and technique questions I would ask before injecting.

Written by (pen name) — editorial research, not medical advice
On this page

The instructions answer the practical question

If stretch marks cover much of the abdomen, I would want someone to show me an appropriate injection site before using the pen. I would not infer that a mark is safe to inject through because the medicine is meant to reach the tissue underneath it.

For the Wegovy single-dose pen, the instructions explicitly say to avoid areas with scars or stretch marks. They also say not to inject into skin that is tender, bruised, red or hard2. That instruction is more useful for choosing a site than speculation about whether absorption through a mark has been studied.

I would identify the exact device first

Wegovy’s prescribing information includes instructions for different presentations. I would use the leaflet supplied with the device I have, rather than assume a video for another pen applies unchanged.

I would check the medicine, prescribed dose and device name, then ask a pharmacist or clinician to demonstrate the sequence. If I cannot find a comfortable, suitable area, I would ask before injecting. I would not let embarrassment about asking turn into a guess about technique.

That includes asking which area another person can help with, if help is needed. A site named in the label still needs to be reachable and usable with the correct device technique.

The label offers more than the abdomen

The labeled injection areas include the abdomen, thigh and upper arm2. I would ask about an alternative if the abdomen has extensive stretch marks, scars or irritated skin. I would not treat using a different approved area as changing the prescription.

The pharmacokinetic section reports similar semaglutide exposure across the listed injection areas2. That comparison does not establish equivalent absorption through scarred, injured or stretch-marked skin. It compares the approved body areas under the conditions studied.

I would keep those two statements together: there are alternative approved areas, and the skin-selection instructions still apply within them. The general exposure finding is not a reason to disregard a specific precaution.

Rotation does not require inventing a complicated system

The instructions say the same body area may be used each week, but not the same exact spot as the previous injection2. I would use a simple note if remembering the last site is difficult.

I would ask the team to show what counts as a different spot and which areas to avoid. I would not create a mandatory monthly rotation pattern or claim that everyone must cycle through four named body parts. The useful routine is one that follows the device instructions and is practical for the person using it.

I would also have the cleaning and disposal steps demonstrated. Knowing the correct area is only one part of using an injection device safely.

What the skin review can and cannot add

A review describes stretch marks, or striae, as changes in skin and connective-tissue architecture1. It does not test semaglutide injections through those marks, measure drug absorption there or provide a reason to overrule the product instructions.

I would not turn a plausible anatomical explanation into “it probably does not matter.” An absence of a direct absorption study would not establish that advice. The current instructions already supply the practical choice: avoid the marked area and ask about a suitable alternative.

Nor would I equate every visible line with a surgical scar. If I am unsure what a particular area is, I would show it to a healthcare professional rather than diagnose its tissue properties myself.

If I am unsure a dose was delivered

I would not inject another dose to compensate for uncertainty. I would follow the device’s instructions for a delivery problem and contact the pharmacist, prescribing team or manufacturer as appropriate. I would explain what happened with the indicator, how long the device was held and any visible leakage.

I would also contact the team about a painful, persistent or concerning skin reaction. A problem with technique or skin deserves an answer rather than repeated attempts in the same uncomfortable area.

For me, the reassuring part is that help can be specific: identify the device, choose suitable skin in an approved area and demonstrate the process. I would rather ask for that demonstration than accept a confident online theory about what is happening underneath a stretch mark.

Frequently asked questions

Can I inject Wegovy through a stretch mark?

The Wegovy single-dose pen instructions say to avoid areas with scars or stretch marks, and skin that is tender, bruised, red or hard. Follow the instructions supplied with the exact device and ask a pharmacist to identify a suitable area.

Does similar exposure across injection areas override the skin precautions?

No. Similar exposure in the abdomen, thigh and upper arm does not establish equivalent absorption through scarred, injured or stretch-marked skin. The skin-selection instructions still apply.

What should I do about a C-section scar?

Avoid scarred skin as directed by the product instructions. Ask the pharmacist or clinician to show a suitable area; the cited sources do not supply a universal distance from a surgical scar.

How should I rotate sites?

The Wegovy instructions allow the same body area each week but say not to use the same exact spot as the previous injection. Ask for a demonstration if the distinction is unclear.

What if I am unsure a dose was delivered?

Do not inject another dose to compensate for uncertainty. Follow the device instructions and contact the pharmacist, prescribing team or manufacturer for help.

References

  1. Borrelli MR, Griffin M, Ngaage LM, Longaker MT, Lorenz HP (2021). Striae Distensae: Scars without Wounds (describes striae as atrophic skin with altered connective tissue architecture and states that their exact pathogenesis remains unknown). Plastic and Reconstructive Surgery. https://pubmed.ncbi.nlm.nih.gov/34181606/
  2. Novo Nordisk (2026). WEGOVY (semaglutide) injection and tablet prescribing information — approved injection sites (abdomen, thigh, upper arm), the instruction to rotate sites with each dose, and the Clinical Pharmacology statement that similar exposure was achieved across all three sites. DailyMed, US National Library of Medicine (SPL ee06186f-2aa3-4990-a760-757579d8f77b). https://www.novo-pi.com/wegovy.pdf

One mom to another, not a doctor: everything here is for learning and figuring out your options, not medical advice, a diagnosis, or a plan for your body. Pregnancy planning and breastfeeding need advice for the exact medicine and formulation. Before you start, stop, or change anything, talk it through with a clinician who actually knows your history.